Verano 10-Q: Q3 Net Loss Narrows to $4M, Cash Builds to $102M, Tax Liability Swells to $411M
VRNO sits 30% above its 52-week low of $3.912 on light trading volume (0.1× avg).
Summary
Verano's Q3 10-Q confirms the $212M revenue and $4M net loss reported in today's 8-K, and adds detail: cash of $102M, $97.9M of nine-month operating cash flow, and a $411M uncertain tax position that hinges on pending IRS guidance for rescheduled medical cannabis.
Key Events · Earnings and Guidance · VRNO
-
Q3 Revenue $212M, Net Loss $4M
Revenue rose 5% to $212,443 thousand from $202,810 thousand, and net loss attributable to Verano narrowed to $(4,065) thousand from $(43,832) thousand a year earlier.
-
Cash Builds on Strong Operating Flow
Cash and equivalents reached $102,054 thousand versus $82,724 thousand at December 31, 2025; nine-month operating cash flow was $97,903 thousand against $39,040 thousand a year earlier.
-
Uncertain Tax Position Grows to $411M
The uncertain tax positions liability rose to $410,939 thousand from $378,261 thousand, reflecting Section 280E exposure while IRS guidance on the April 26, 2026 medical cannabis rescheduling remains pending.
-
Debt at $390M After March Refinancing
Total debt was $390,177 thousand, including a $100,000 thousand revolver balance and a $189,750 thousand term loan under the 2026 Credit Agreement; the company reported covenant compliance.
Analysis · VRNO · Industrial Applications And Services
The headline numbers match this morning's 8-K, but the full quarterly report reveals the balance sheet behind them. Cash rose to $102.1M from $82.7M at year-end, powered by $97.9M of nine-month operating cash flow, while the uncertain tax position tied to Section 280E grew to $410.9M from $378.3M. That tax liability is the swing factor: medical cannabis rescheduling to Schedule III took effect April 26, 2026, and the D.C. Circuit refused to stay it on September 9, 2026, but IRS guidance is still pending, leaving unresolved how much of that $411M reserve is ultimately owed. Debt sits at $390.2M after the March refinancing, with the revolver fully drawn at $100M.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VRNO was trading at $5.10 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $3.91 to $9.75. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.